Endoscopic evaluation of the comparative effects of acetylsalicylic acid and choline magnesium trisalicylate on human gastric and duodenal mucosa.

Author: DotevallG, KilanderA

Paper Details 
Original Abstract of the Article :
A new salicylate product, choline magnesium trisalicylate (Trilisate tablets), and acetylsalicylic acid were compared for their local effects in equipotent doses on the gastroduodenal mucosa in a randomized, double-blind, cross-over study, using 10 healthy volunteers. After five-day periods of admin...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1093/rheumatology/22.1.36

データ提供:米国国立医学図書館(NLM)

Salicylates and the Gastroduodenal Mucosa: A Tale of Two Treatments

The use of [salicylates] for pain relief is widespread, but concerns about their potential impact on the [gastroduodenal mucosa] remain a subject of ongoing research. This study delves into the comparative effects of [acetylsalicylic acid] (ASA) and [choline magnesium trisalicylate] (Trilisate) on the [gastroduodenal mucosa] of [10 healthy volunteers]. Both drugs were administered in [equipotent doses] over a [five-day period], followed by [gastroduodenoscopy] to assess mucosal changes.

Trilisate Shows Promise in Minimizing Mucosal Damage

The results reveal a significant difference in the incidence of mucosal lesions between the two drugs. While [ASA] led to [multiple mucosal lesions] in all participants, [Trilisate] resulted in only [slight mucosal changes] in a limited number of individuals. This suggests that [Trilisate] may offer a more [gastric-friendly] alternative to [ASA] for individuals seeking pain relief while minimizing the risk of [gastroduodenal damage].

Navigating the Oasis of Pain Relief with Minimal Gastric Impact

The findings of this study provide valuable information for healthcare providers and patients seeking effective pain relief while minimizing the potential for [gastrointestinal complications]. While [ASA] remains a widely used analgesic, the data suggests that [Trilisate] may represent a promising option for those with a higher risk of [gastric irritation]. As always, consulting with a healthcare professional is crucial for determining the most suitable treatment approach based on individual needs and medical history.

Dr.Camel's Conclusion

Just as a camel adapts to the harsh conditions of the desert, our bodies are constantly seeking to maintain equilibrium. This study sheds light on the potential impact of different salicylates on the delicate balance of the gastroduodenal mucosa. Trilisate emerges as a potentially more gentle option for pain relief, but as always, it's best to consult with your healthcare professional for personalized advice and to ensure the most appropriate treatment for your unique needs.

Date :
  1. Date Completed 1983-04-21
  2. Date Revised 2019-08-29
Further Info :

Pubmed ID

6337663

DOI: Digital Object Identifier

10.1093/rheumatology/22.1.36

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.